_256_384.jpg)
News | September 18, 2021
India extends concession on life-saving Covid-19 drugs till December 2021
The council has also reduced the GST to 5 per cent on a few more Covid-19 medicines
The council has also reduced the GST to 5 per cent on a few more Covid-19 medicines
This award is open to all currently operational laboratories pertaining to testing, calibration & medical including their proficiency testing providers & reference material producers located in India
A long waiting period for critical equipment and a 50% hike in the cost of APIs imported from China are among the immediate challenges
As of FY21, it is the largest independent medical device company and the second-largest company overall, in the surgical consumables market in India with a 7.91 per cent share based on the value
Amptron’s R &D is based out of the US and this will enable Max to obtain US and other global certifications. Max will retain the right to market, sell and distribute the products in India.
The agreement follows positive NICE recommendation and commits to deliver Leqvio (inclisiran) access via a population health management approach identifying eligible patients across England
Union Minister addresses the 13th CII Global MedTech Summit on the sunrise medical devices sector in India
_256_384.jpeg)
The company aims to continue its expansion via organic and inorganic routes to increase production capacity and product portfolio
Trillium’s portfolio includes biologics that are designed to enhance the ability of patients’ innate immune system to detect and destroy cancer cells
Agilent Technologies Inc. announced the contribution of Agilent AriaMx Real-Time qPCR instruments to five research hospitals in India to support their COVID-19 initiatives and help them serve the community at large
Subscribe To Our Newsletter & Stay Updated
